Topic Review - Newest First (only newest 5 are displayed)
ikhan700
Re: Nanotech in Lahore
HIV behaves like a autoimmune disease, along with immune suppression.
IgG IN IVIg has been used to stop HIV in its tracks.
Nanoparticles of silver have been used to get rid of HIV .
Some of this research is not avaliable to the general public.
To trat a disease one needs to know what is the cause! What is the your main target in HIV? Since HIV is a new Virus where did it come from?
You do your research and I will give you the rest of the answers.
I.Khan
yusman
Re: Nanotech in Lahore
Is it the same nanotechnology, researchers are using to aim specific target biomolecules. What is the target in case of HIV. Can you explain and refer to any website it will be very useful for all of us.
oncoman
Re: Nanotech in Lahore
There is absolutely no level I evidence that nanotechnology is useful in "CURE" of cancer. The current investigational uses of this technology in the field of oncology are limited to diagnostic rather than therapeutic fileds.
The others i.e. auto immune disorders I don't know about.
[Edited by oncoman on 24-03-2007 at 12:26 PM GMT]
rqayyum
Re: Nanotech in Lahore
Dear Ijaz Sahib, please check my post above. I didn't ask about ABPN. In fact, I wrote that it is a member of ABMS. What I was asking was that whether ABNP (and not ABPN) was member of ABMS or not.
ijazali
Re: Re: Nanotech in Lahore
pls see this website
http://www.abpn.com/
Pls also see the history of ABNP as well. Its available on internet.
about abpn - our history
The American Board of Psychiatry and Neurology, Inc. (ABPN) is a nonprofit corporation that was founded in 1934 following conferences of committees appointed by the American Psychiatric Association, the American Neurological Association, and the then Section on Nervous and Mental Diseases of the American Medical Association. This action was taken as a method of identifying the qualified specialists in psychiatry and neurology.
The ABPN is one of 24 member boards of the American Board of Medical Specialties (ABMS).
Since 1935, when its first examination was delivered, the ABPN has been serving the public interest and promoting excellence in the practices of psychiatry and neurology through its certification and maintenance of certification processes. These processes are designed to identify qualified specialists through rigorous credential and training requirements, and successful completion of the Part I (computer-administered), and Part II (oral) board examinations for psychiatry, neurology, or neurology with special qualification in child neurology. ABPN committees are dedicated to developing tests that assess current scientific knowledge and clinical expertise required to achieve and maintain Board-certification.
Additionally, over the past several decades, the ABPN (sometimes in collaboration with other member boards) has sought from the ABMS, and gained approval for recognition of 11 subspecialties as listed below:
ABMS
Approval First
Examination Subspecialty
* 1959 Child and Adolescent Psychiatry
1989 1991 Geriatric Psychiatry
1990 1992 Clinical Neurophysiology
1991 1993 Addiction Psychiatry
1992 1994 Forensic Psychiatry
1998 2000 Pain Medicine
1999 2001 Neurodevelopmental Disabilities
2003 2005 Psychosomatic Medicine
2003 2005 Vascular Neurology
2005 anticipated 2008 Neuromuscular Medicine
2005 anticipated 2007 Sleep Medicine
*Certificates were issued prior to 1972 when ABMS recognition procedures were established.
As mandated by the ABMS, the ABPN continues making progress in the development of its Maintenance of Certification (MOC) program. MOC programs are designed to help assure the public that our Diplomates practice their specialties to the highest standards through four measurable components; professional standing, self-assessment and lifelong learning, cognitive expertise, and performance in practice.
ijaz
